Moderna Inc (MRNA)
40.28
+0.69
(+1.74%)
USD |
NASDAQ |
Dec 24, 13:00
40.10
-0.18
(-0.45%)
After-Hours: 13:47
Moderna Research and Development Expense (Quarterly): 1.137B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Eli Lilly and Co | 2.734B |
Merck & Co Inc | 5.862B |
Pfizer Inc | 2.598B |
Novavax Inc | 87.16M |
Biogen Inc | 542.70M |